9.7 Pharmacogenomics ........................................................................................... 94 95 96 97 97 97 98 99 99 100 101 102 103 103 104 104 104 105 105 106 106 107 107 107 107 107 109109 121 121Clinical Protocol BMS-986226CA021002 anti-ICOS Revised Protocol No.: 04Date: 31-May-2019 8 Approved 5.0 v Approved 1.0 v 9.9 Health Ec onomics or Medical Resource Utilization and Health Economics ... 10 STATISTICAL CONSIDERATIONS ....................................................................